Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
EE.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
EE.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EE.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EE.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DV.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
DV.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DV.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
DV.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
DV.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
DV.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
DV.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DV.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
ES.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
ES.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
ES.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
ES.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
ES.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
ES.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
ES.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
ES.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.41EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.41EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.41ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.41ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.5.41EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.41EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.41ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.41ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.463EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.463EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.463ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.463ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.463EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.463EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.463ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.463ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
U.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
U.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
U.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
U.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
U.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
U.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
U.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
U.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.373EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.373EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.373ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.373ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.373EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.373EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used